Patent details

EP2970123 Title: CRYSTALLINE DIHYDROCHLORIDE HYDRATE SALT OF OMECAMTIV MECARBIL AND PROCESS FOR ITS PREPARATION

Basic Information

Publication number:
EP2970123
PCT Application Number:
US2014027146
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147203699
PCT Publication Number:
WO2014152270
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE DIHYDROCHLORIDE HYDRATE SALT OF OMECAMTIV MECARBIL AND PROCESS FOR ITS PREPARATION
French Title of Invention:
SEL DIHYDROCHLORIDE HYDRATE CRISTALLIN DE OMECAMTIV MECARBIL ET SON PROCÉDÉ DE PRÉPARATION
German Title of Invention:
KRISTALLINES DIHYDROCHLORID-HYDRAT-SALZ VON OMECAMTIV MECARBIL UND VERFAHREN ZU SEINER HERSTELLUNG
SPC Number:

Dates

Filing date:
14/03/2014
Grant date:
14/08/2019
EP Publication Date:
20/01/2016
PCT Publication Date:
25/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/08/2019
EP B1 Publication Date:
14/08/2019
EP B2 Publication Date:
10/12/2025
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/12/2025
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Name:
Cytokinetics, Inc.
Address:
350 Oyster Point Boulevard, South San Francisco, CA 94080, United States (US)

History of Owners

From:
07/08/2019
To:
29/04/2022

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Name:
Cytokinetics, Inc.
Address:
280 East Grand Avenue, South San Francisco, CA 94080, United States (US)

Agent

Name:
ARONOVA S.A.
From:
25/09/2019
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
WOO, Jacqueline
Address:
Canada (CA)

2

Name:
NAGAPUDI, Karthik
Address:
United States (US)

3

Name:
MENNEN, Steven
Address:
United States (US)

4

Name:
LANGILLE, Neil, Fred
Address:
United States (US)

5

Name:
MORRISON, Henry
Address:
United States (US)

6

Name:
HANSEN, Karl, Bennett
Address:
United States (US)

7

Name:
MUCI, Alex
Address:
United States (US)

8

Name:
WALKER, Shawn
Address:
United States (US)

9

Name:
CUI, Sheng
Address:
United States (US)

10

Name:
BERNARD, Charles
Address:
United States (US)

11

Name:
MORGAN, Bradley, Paul
Address:
United States (US)

12

Name:
ALLGEIER, Alan, Martin
Address:
United States (US)

Priority

Priority Number:
201361785763 P
Priority Date:
14/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
C07D 213/75; A61P 9/00; A61P 9/04; A61K 9/20; A61K 31/496;

Publication

European Patent Bulletin

1

Issue number:
201933
Publication date:
14/08/2019
Description:
Grant (B1)

2

Issue number:
202550
Publication date:
10/12/2025
Description:
Patent maintained (B2 publication)

3

Issue number:
202204
Publication date:
26/01/2022
Description:
International Patent Classification Changed

4

Issue number:
202204
Publication date:
26/01/2022
Description:
Title of invention Modified

5

Issue number:
202222
Publication date:
01/06/2022
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
31/03/2027
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/02/2026
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
25/09/2019 Power Of Attorney 1
03/10/2019 Outgoing Correspondence 1